BURLINGAME, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team ...
3d
Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.
As of 8:05:17 am GMT+1. Market open.
As of 12:55:43 PM EST. Market Open.
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP tumbled 10.23% to $8.51 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP ...
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP tumbled 10.22% to $8.78 Tuesday, on what proved to be an all-around mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback